関節内補充療法の世界市場:インサイト、機会分析、市場シェア、予測

◆英語タイトル:Viscosupplementation Global Analysis & Market Insights, Opportunity, Analysis, Market Shares And Forecast 2016 – 2022
◆商品コード:OCCAM60562
◆発行会社(調査会社):Occams Research
◆発行日:2016年4月5日
◆ページ数:140
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆調査対象地域:グローバル
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD3,900 ⇒換算¥444,600見積依頼/購入/質問フォーム
Enterprisewide Price (Global Site License)USD6,900 ⇒換算¥786,600見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご確認ください。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(支払期限と方法は調整可能、振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はOccams Research社の日本における正規販売代理店です。Occams Research社の概要及び新刊レポートはこちらでご確認いただけます。
【レポートの概要】

Viscosupplementation is the latest treatment which is being rapidly adapted these days for the treatment of osteoarthritis. It is a method of injecting hyaluronic acid in stiff joints specially knees. Due to the global adoption, the Viscosupplementation market is expected to hit $1756 million during 2015-2021 growing at an impressive CAGR of 6% during the forecast period. The main reason behind a solid growth of Viscosupplementation market on the global level is the rapid rise in the elderly population suffering from osteoarthritis. This elderly population is expected to increase in future due to advancement in the healthcare facilities which would ultimately require Disco supplementation for patients suffering from osteoarthritis during the forecast period.
Further, Intra-articular Viscosupplementation with hyaluronic acid (HA) is gaining a good acceptance as a therapeutic alternative to knee replacement surgery in OA in the past decade. North America is expected to be the largest market for Viscosupplementation during the forecast period in which the US being the major contributor to the global market for Viscosupplementation. On the flip side, APAC is seeing good growth in demand for Viscosupplementation fluids due to rising cases of osteoarthritis in countries such as India and China. However, the growing concern of physicians who updated American Academy of Orthopedic Surgeons (AAOS) and Osteoarthritis Research Society International (OARSI) treatment guidelines for knee OA will affect in rising insurance denials for Viscosupplementation. Further the price competition and product differentiation are some of the factors that can restrict the smooth growth of the market during the forecast period.

【レポートの目次】

1. INTRODUCTION
1.1. EXECUTIVE SUMMARY
1.2. ESTIMATION METHODOLOGY
2. MARKET OVERVIEW
2.1. MARKET DEFINITION AND SCOPE
2.2. KEY FINDINGS
2.3. PARAMETRIC ANALYSIS
2.4. KEY MARKET INSIGHTS
2.4.1. TOP 3 EMERGING COUNTRIES
2.4.2. TOP 3 REVENUE GENERATING SEGMENTS
2.4.3. TOP GROWING MARK
2.4.4. TOP 3 GEOGRAPHY
2.5. COMPETITIVE LANDSCAPE
2.5.1. MARKET SHARE ANALYSIS
2.5.2. TOP WINNING STRATEGIES
2.5.3. CASE STUDIES: TOP COMPETITIVE MOVES
2.6. PORTER’S FIVE FORCE MODEL
2.6.1. THREAT OF NEW ENTRANTS
2.6.2. THREAT OF SUBSTITUTE PRODUCTS OR SERVICES
2.6.3. BARGAINING POWER OF BUYER
2.6.4. BARGAINING POWER OF SUPPLIER
2.6.5. INTENSITY OF COMPETITIVE RIVALRY
2.7. KEY BUYING CRITERIA
2.8. STRATEGIC RECOMMENDATIONS
2.9. STRATEGIC CONCLUSIONS
3. MARKET DETERMINANTS
3.1. MARKET DRIVERS
3.1.1. RISING PREVALENCE OF OA
3.1.2. VISCOSUPPLEMENTATION DELAYS TOTAL KNEE REPLACEMENT
3.1.3. SIDE EFFECTS OF NSAIDS, CORTICOSTEROIDS, AND NARCOTICS
3.1.4. DIRECT-TO-CONSUMER MARKETING

3.2. MARKET RESTRAINTS
3.2.1. UNFAVOURABLE REIMBURSEMENT SCENARIO
3.2.2. PRICING EROSION
3.2.3. COST EFFECTIVE PHARMACOLOGICAL THERAPIES
3.2.4. RISING POPULARITY OF PRP INJECTION TO IMPACT VISCOSUPPLEMENTATION
3.2.5. COST-CONSCIOUS PATIENTS IN EMERGING COUNTRIES
3.3. MARKET OPPORTUNITIES
3.3.1. EXPANDING INDICATIONS
3.3.2. NEW GENERATION HA DERIVATIVES
3.3.3. INCREASED USE AFTER ARTHROSCOPIC SURGERIES
3.3.4. SELF-PAY MARKET
3.3.5. EMERGING COUNTRIES
4. SECTOR ANALYSIS
4.1. PARENT MARKET
4.2. COMPETITORS MARKET
4.3. ALTERNATIVE MARKET
5. MARKET SEGMENTATION
6. GEOGRAPHIC ANALYSIS
6.2. NORTH AMERICA
6.2.1. NORTH AMERICA VISCOSUPPLEMENTATION MARKET BY APPLICATION, 2014-2021 ($BILLION)
6.2.2. NORTH AMERICA VISCOSUPPLEMENTATION MARKET BY REGION, 2014-2021 ($BILLION)
6.2.2.1. US VISCOSUPPLEMENTATION MARKET BY APPLICATION, 2014-2021 ($BILLION)
6.2.2.2. CANADA VISCOSUPPLEMENTATION MARKET BY APPLICATION, 2014-2021 ($BILLION)
6.2.2. 3. MEXICO VISCOSUPPLEMENTATION MARKET BY APPLICATION, 2014-2021 ($BILLION)
6.3 EUROPE
6.3.1. EUROPE VISCOSUPPLEMENTATION MARKET BY APPLICATION, 2014-2021 ($BILLION)
6.3.2. EUROPE VISCOSUPPLEMENTATION MARKET BY REGION, 2014-2021 ($BILLION)
6.3.2.1. GERMANY VISCOSUPPLEMENTATION MARKET BY APPLICATION, 2014-2021 ($BILLION)
6.3.3.2. UK VISCOSUPPLEMENTATION MARKET BY APPLICATION, 2014-2021 ($BILLION)
6.3.3.3. RUSSIA VISCOSUPPLEMENTATION MARKET BY APPLICATION, 2014-2021 ($BILLION)
6.4. ASIA PACIFIC
6.4.1. ASIA PACIFIC VISCOSUPPLEMENTATION MARKET BY APPLICATION, 2014-2021 ($BILLION)
6.4.2. ASIA PACIFIC VISCOSUPPLEMENTATION MARKET BY REGION, 2014-2021 ($BILLION)
6.4.2.1. CHINA VISCOSUPPLEMENTATION MARKET BY APPLICATION, 2014-2021 ($BILLION)
6.4.2.2. INDIA VISCOSUPPLEMENTATION MARKET BY APPLICATION, 2014-2021 ($BILLION)
6.4.2.3. SOUTH KOREA VISCOSUPPLEMENTATION MARKET BY APPLICATION, 2014-2021 ($BILLION)
6.5. MIDDLE EAST & AFRICA
6.5.1. MIDDLE EAST & AFRICA VISCOSUPPLEMENTATION MARKET BY APPLICATION, 2014-2021 ($BILLION)
6.5.2. MIDDLE EAST & AFRICA VISCOSUPPLEMENTATION MARKET BY REGION, 2014-2021 ($BILLION)
6.6. CENTRAL & SOUTH AMERICA
6.6.1. CENTRAL & SOUTH AMERICA VISCOSUPPLEMENTATION MARKET BY APPLICATION, 2014-2021 ($BILLION)
6.6.2. CENTRAL & SOUTH AMERICA VISCOSUPPLEMENTATION MARKET BY REGION, 2014-2021 ($BILLION)
6.6.2.1. BRAZIL VISCOSUPPLEMENTATION MARKET BY APPLICATION, 2014-2021 ($BILLION)
7 COMPANY PROFILES
# 7.1. AJINOMOTO COMPANY INCORPORATION
# 7.2. AB ENZYMES
# 7.3. BASF SE
# 7.4. AMANO ENZYME INC
# 7.5. THE DOW CHEMICAL COMPANY
# 7.6. ARCHER DANIELS MIDLAND COMPANY
# 7.7. NOVOZYMES A/S
# 7.8. CARGILL INCORPORATION.
# 7.9. EVONIK INDUSTRIES AG
# 7.10. DU PONT DANISCO A/S
# 7.11. DSM
# 7.12. CHR
# 7.13. FUSO CHEMICAL
# 7.14. HOFFMANN-LA ROCHE
# 7.15. AMINO

TABLE LIST

TABLE # 1 US PROCEDUREAL TRENDS FOR VISCOSUPPLEMENTATION, BY JOINT TYPE, 2014-2021
TABLE # 2 US PROCEDUREAL TRENDS FOR VISCOSUPPLEMENTATION, BY TREATMENT REGIMEN, 2014-2021
TABLE # 3 5EU PROCEDUREAL TRENDS FOR VISCOSUPPLEMENTATION, BY JOINT TYPE, 2014-2021
TABLE # 4 EUROPE PROCEDURE TRENDS FOR VISCOSUPPLEMENTATION, BY TREATMENT REGIMEN, 2014-2021
TABLE # 5 APAC PROCEDURE TRENDS FOR VISCOSUPPLEMENTATION, BY JOINT TYPE, 2014-2021
TABLE # 6 APAC PROCEDURE TRENDS FOR VISCOSUPPLEMENTATION, BY TREATMENT REGIMEN, 2014-2021
TABLE # 7 BRAZIL PROCEDURE TRENDS FOR VISCOSUPPLEMENTATION, BY JOINT TYPE, 2014-2021
TABLE # 8 BRAZIL PROCEDURE TRENDS FOR VISCOSUPPLEMENTATION, BY TREATMENT REGIMEN, 2014-2021
TABLE # 9 DIFFERENCES BETWEEN US FDA APPROVAL AND EU CE MARKING OF MEDICAL DEVICES
TABLE # 10 US MEDICARE ASPS* FOR VISCOSUPPLEMENTATION PRODUCTS (2014–2015)
TABLE # 11 PROBLEMS ASSOCIATED WITH KNEE REPLACEMENT
TABLE # 12 SIDE-EFFECTS CAUSED BY NSAIDS
TABLE # 13 SIDE EFFECTS OF CORTICOSTEROIDS
TABLE # 14 SIDE EFFECTS OF NARCOTICS
TABLE # 15 VISCOSUPPLEMENTATION DOSING
TABLE # 16 MEDICAL NECESSITIES FOR THE PROCESS
TABLE # 17 TOTAL HEALTH EXPENDITURE PER CAPITA INCOME IN $ IN 2015
TABLE # 18 PRODUCT PROFILE (ADANT)
TABLE # 19 PRODUCT PROFILE (ARTHRUM)
TABLE # 20 ARTHRUM COMPOSITION AND RATIO IN CAPSULES
TABLE # 21 PRODUCT PROFILE (CURAVISC)
TABLE # 22 PRODUCT PROFILE (DUROLANE)
TABLE # 23 PRODUCT PROFILE (EUFLEXXA)
TABLE # 24 PRODUCT PROFILE (FERMATHRON)
TABLE # 25 PRODUCT PROFILE (GEL-ONE)
TABLE # 26 PRODUCT PROFILE (GO-ON)
TABLE # 27 PRODUCT PROFILE (JONEXA)
TABLE # 28 PRODUCT PROFILE (JONEXA)
TABLE # 29 PRODUCT PROFILE (NEOVISC)
TABLE # 30 PRODUCT PROFILE (ORTHOVISC AND MONOVISC)
TABLE # 31 PRODUCT PROFILE (OSTENIL)
TABLE # 32 PRODUCT PROFILE (RECOSYN)
TABLE # 33 PRODUCT PROFILE (RENEHAVIS)
TABLE # 34 PRODUCT PROFILE (SUPARTZ/ARTZ)
TABLE # 35 PRODUCT PROFILE (SUPLASYN)
TABLE # 36 PRODUCT PROFILE (SUVENYL)
TABLE # 37 PRODUCT PROFILE (SYNOCROM)
TABLE # 38 PRODUCT PROFILE (SYNOLIS V-A)
TABLE # 39 PRODUCT PROFILE (SYNOVIAL)
TABLE # 40 PRODUCT PROFILE (SYNVISC AND SYNVISC-ONE)
TABLE # 41 EACH 1 ML OF GEL-SYN CONTAINS:
TABLE # 42 SEIKAGAKU CORPORATION PRODUCTS PORTFOLIO
TABLE # 43 SCOT ANALYSIS – SEIKAGAKU CORPORATION
TABLE # 44 BIOVENTUS LLC PRODUCTS PORTFOLIO
TABLE # 45 SCOT ANALYSIS – BIOVENTUS LLC
TABLE # 46 DEPUY SYNTHES PRODUCTS PORTFOLIO
TABLE # 47 SCOT ANALYSIS – DEPUY SYNTHES
TABLE # 48 ZIMMER BIOMET INC PRODUCTS PORTFOLIO
TABLE # 49 SCOT ANALYSIS – ZIMMER BIOMET INC
TABLE # 50 SANOFI PRODUCTS PORTFOLIO
TABLE # 51 SCOT ANALYSIS – SANOFI
TABLE # 52 ANIKA THERAPEUTICS PRODUCTS PORTFOLIO
TABLE # 53 SCOT ANALYSIS – ANIKA THERAPEUTICS
TABLE # 54 CHUGAI PHARMACEUTICALS PRODUCTS PORTFOLIO
TABLE # 55 SCOT ANALYSIS – CHUGAI PHARMACEUTICALS
TABLE # 56 FERRING HOLDINGS PRODUCTS PORTFOLIO
TABLE # 57 SCOT ANALYSIS – FERRING HOLDINGS
TABLE # 58 FIDIA FARMACEUTICI S.P.A. PRODUCTS PORTFOLIO
TABLE # 59 SCOT ANALYSIS – FIDIA FARMACEUTICI S.P.A.
TABLE # 60 MEDA AB PRODUCTS PORTFOLIO
TABLE # 61 SCOT ANALYSIS – MEDA AB
TABLE # 62 GLOBAL VISCOSUPPLEMENTATION MARKET BY REGION, 2014-2021 ($ MILLION)
TABLE # 63 GLOBAL VISCOSUPPLEMENTATION MARKET REVENUE ($ MILLION), BY SEGMENT, 2014-2021
TABLE # 64 SINGLE INJECTION IN VISCOSUPPLEMENTATION COST AND DIFFERENT BRAND
TABLE # 65 ONE-INJECTION MARKET, BY REGION 2014-2021($MILLION)
TABLE # 66 THREE-INJECTION MARKET, BY REGION 2014-2021($ MILLION)
TABLE # 67 MULTIPLE INJECTIONS IN VISCOSUPPLEMENTATION
TABLE # 68 GLOBAL VISCOSUPPLEMENTATION MARKET BY GEOGRAPHY, 2014-2021 ($ MILLION)
TABLE # 69 US VISCO SUPPLEMENTATION MARKET BY REVENUE ($ MILLION) 2014-2021
TABLE # 70 FRANCE VISCO SUPPLEMENTATION MARKET BY REVENUE ($ MILLION) 2014-2021
TABLE # 71 GERMANY VISCO SUPPLEMENTATION MARKET BY REVENUE ($ MILLION), 2014-2021
TABLE # 72 SPAIN VISCOSUPPLEMENTATION MARKET BY REVENUE ($ MILLION), 2014-2021
TABLE # 73 UK VISCO SUPPLEMENTATION MARKET BY REVENUE($ MILLION), 2014-2021
TABLE # 74 JAPAN VISCOSUPPLEMENTATION MARKET BY REVENUE ($ MILLION), 2014-2021
TABLE # 75 BRAZIL VISCOSUPPLEMENTATION MARKET BY REVENUE($ MILLION), 2014-2021
TABLE # 76 CHINA VISCO SUPPLEMENTATION MARKET BY REVENUE($ MILLION), 2014-2021
TABLE # 77 INDIA VISCOSUPPLEMENTATION MARKET BY REVENUE ($ MILLION), 2014-2021

FIGURES LIST

FIGURE # 1 GLOBAL VISCOSUPPLEMETATION PROCEDURAL TRENDS BY TREATMENT REGIME (%) 2014 AND 2021
FIGURE # 2 GLOBAL VISCOSUPPLEMENTATION PROCEDURAL TRENDS BY JOINT TYPE (%) 2014 AND 2021
FIGURE # 3 US ADOPTION TREND FOR VISCOSUPPLEMENTATION, BY TREATMENT REGIMEN, 2014
FIGURE # 4 US PROCEDURE TRENDS FOR VISCOSUPPLEMENTATION, BY TREATMENT REGIMEN, 2012–2021
FIGURE # 5 5EU PROCEDURE TRENDS FOR VISCOSUPPLEMENTATION, BY JOINT TYPE, 2014
FIGURE # 6 5EU ADOPTION TRENDS FOR VISCOSUPPLEMENTATION, BY TREATMENT REGIMEN, 2014
FIGURE # 7 5EU PROCEDURE TRENDS FOR VISCOSUPPLEMENTATION, BY TREATMENT REGIMEN, 2012–2021
FIGURE # 8 APAC PROCEDURE TRENDS FOR VISCOSUPPLEMENTATION, BY TREATMENT REGIMEN, 2012–2021
FIGURE # 9 APAC PROCEDURE TRENDS FOR VISCOSUPPLEMENTATION, BY JOINT TYPE, 2014
FIGURE # 10 APAC ADOPTION TREND FOR VISCOSUPPLEMENTATION, BY TREATMENT REGIMEN, 2014
FIGURE # 11 BRAZIL PROCEDURE TRENDS FOR VISCOSUPPLEMENTATION, BY JOINT TYPE, 2014
FIGURE # 12 BRAZIL ADOPTION TREND FOR VISCOSUPPLEMENTATION, BY TREATMENT REGIMEN, 2014
FIGURE # 13 BRAZIL PROCEDURE TRENDS FOR VISCOSUPPLEMENTATION, BY TREATMENT REGIMEN, 2012–2021
FIGURE # 14 GLOBAL VISCOSUPPLEMENTATION MARKET ACCESS BY REGION 2014-2021 (%)
FIGURE # 15 PAYER MIX FOR VISCOSUPPLEMENTATION IN THE US, 2014
FIGURE # 16 PAYER MIX FOR VISCOSUPPLEMENTATION IN FRANCE, 2014
FIGURE # 17 PAYER MIX FOR VISCOSUPPLEMENTATION IN THE UK, 2014
FIGURE # 18 PAYER MIX FOR VISCOSUPPLEMENTATION IN SPAIN, 2014
FIGURE # 19 PAYER MIX FOR VISCOSUPPLEMENTATION IN CHINA, 2014
FIGURE # 20 LIFE TIME RISK OF SYMPTOMATIC OSTEOARTHRITIS
FIGURE # 21 GLOBAL PREVALENCE ARTHRITIS BY AGE (%) IN 2014
FIGURE # 22 COMMONLY USED NSAIDS, CORTICOSTEROIDS, NARCOTICS
FIGURE # 23 ADVANTAGES OF DIRECT-TO-CONSUMER MARKETING
FIGURE # 24 THE COMMON PHARMACOLOGICAL THERAPIES AVAILABLE FOR OA
FIGURE # 25 AVERAGE PER CAPITA INCOME IN DEVELOPED AND DEVELOPING COUNTRIES IN 2014
FIGURE # 26 HYALURONIC ACID DERIVATIVES
FIGURE # 27 STEPS INCLUDED IN SELF PAY MARKET
FIGURE # 28 GROWTH OF VISCOSUPPLEMENTATION MARKET IN APAC REGION IN US $ MILLION 2015-2020
FIGURE # 29 FEATURES OF NEOVISC
FIGURE # 30 US VISCOSUPPLEMENTATION MARKET BY JOINT TYPE IN 2014(%)
FIGURE # 31 FRANCE, GERMANY, ITALY SPAIN AND UK VISCOSUPPLEMENTATION MARKET GROWTH 2014-2021($ MILLION)
FIGURE # 32 INDIA, CHINA AND JAPAN VISCOSUPPLEMENTATION MARKET GROWTH 2014-2021($ MILLION)
FIGURE # 33 GLOBAL VISCOSUPPLEMENTATION ONE-INJECTION MARKET REVENUE ($M) 2012–2021
FIGURE # 34 GLOBAL VISCOSUPPLEMENTATION THREE-INJECTION MARKET REVENUE ($M), BY REGION, 2012–2021
FIGURE # 35 FIVE-INJECTION MARKET, BY COUNTRY 2012–2021($ MILLION)
FIGURE # 36 GLOBAL VISCOSUPPLEMENTATION FIVE-INJECTION MARKET REVENUE ($ MILLION), BY REGION, 2012–2021
FIGURE # 37 GROWTH IN NUMBER OF PATIENTS SUFFERING FROM OSTEOARTHRITIS BY GENDER (2005-2030)
FIGURE # 38 FRANCE VISCOSUPPLEMENTATION MARKET REVENUE $ MILLION 2014-2021
FIGURE # 39 CAUSES OF OSTEOARTHRITIS
FIGURE # 40 GERMANY VISCOSUPPLEMENTATION MARKET REVENUE $MILLION 2014-2021
FIGURE # 41 HIP REPLACEMENT SURGERY PER 100 000 POPULATION 2013
FIGURE # 42 ITALY VISCOSUPPLEMENTATION MARKET REVENUE $ MILLION 2014-2021
FIGURE # 43 REDUCTION IN PAIN AND STIFFNESS AFTER MONO INJECTION
FIGURE # 44 SPAIN VISCOSUPPLEMENTATION MARKET REVENUE $ MILLION 2014-2021
FIGURE # 45 NUMBER OF OSTEOARTHRITIS PATIENTS IN SPAIN BY AGE
FIGURE # 46 KNEE OPERATIONS FOR OBESE PEOPLE IN 2012-13 BY GENDER
FIGURE # 47 UK VISCOSUPPLEMENTATION MARKET REVENUE $ MILLION 2014-2021
FIGURE # 48 JAPAN VISCOSUPPLEMENTATION MARKET REVENUE $ MILLION 2014-2021
FIGURE # 49 PREVALENCE OF KNEE OSTEOARTHRITIS IN JAPAN BY GENDER IN 2014
FIGURE # 50 BRAZIL VISCOSUPPLEMENTATION MARKET REVENUE $ MILLION 2014-2021
FIGURE # 51 HEALTH EXPENDITURE AS PERCENTAGE OF GDP IN 2013
FIGURE # 52 INDIA VISCOSUPPLEMENTATION MARKET REVENUE $ MILLION 2014-2021



【レポートのキーワード】

関節内補充療法

★調査レポート[関節内補充療法の世界市場:インサイト、機会分析、市場シェア、予測]販売に関する免責事項
★調査レポート[関節内補充療法の世界市場:インサイト、機会分析、市場シェア、予測]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆